Cradle

Cradle is an AI-driven protein engineering platform that helps biotech and pharmaceutical companies accelerate candidate discovery. The platform generates optimized protein designs while considering multiple constraints—binding affinity, expression levels, stability, and more—in a single iteration cycle. Rather than testing countless variations in the lab, researchers use Cradle's predictive models to narrow down the most promising candidates, dramatically reducing time and cost.

Highlights

• Multi-property optimization for proteins including antibodies, enzymes, vaccines, and peptides
• Private machine learning models trained exclusively on your organization's proprietary data
• Iterative improvement where models learn from each experimental round
• Typical customers report 2-12x faster development timelines
• Full intellectual property ownership with subscription-based pricing

The platform is used by major pharmaceutical and biotech companies for therapeutic development, industrial enzyme design, vaccine development, and food ingredient optimization. Cradle is designed for research teams who want to harness AI for molecular design without compromising intellectual property.